Viatris (VTRS) Assets Average (2020 - 2026)
Viatris (VTRS) posted quarterly Assets Average of $37.0 billion for Q1 2026, down 7.44% year-over-year from $40.0 billion in Q1 2025, and down 1.45% quarter-over-quarter from $37.6 billion in Q4 2025.
Viatris (VTRS) Assets Average (2020 - 2026) Analysis & Trends
Viatris' Assets Average history runs 7 years deep, the most recent figure standing at $37.0 billion for Q1 2026.
- In Q1 2026, Assets Average fell 7.44% year-over-year to $37.0 billion; the TTM figure through Mar 2026 stood at $37.0 billion (down 7.44% YoY), while the FY2025 annual figure was $39.3 billion, down 11.76% from the prior year.
- Assets Average for Q1 2026 stood at $37.0 billion, down from $37.6 billion in the prior quarter.
- The five-year high for Assets Average was $54.2 billion in Q1 2022, with the low at $37.0 billion in Q1 2026.
- The 5-year median for Assets Average is $47.5 billion (2024), against an average of $45.6 billion.
- The sharpest annual moves came in 2023 and 2025: Assets Average declined 2.29% in 2023, then retreated 17.04% in 2025.
- Viatris' Assets Average stood at $49.3 billion in 2022, then decreased by 2.29% to $48.2 billion in 2023, then decreased by 10.55% to $43.1 billion in 2024, then fell by 12.92% to $37.6 billion in 2025, then dropped by 1.45% to $37.0 billion in 2026.
- Business Quant data shows VTRS's Assets Average at $37.0 billion in Q1 2026, $37.6 billion in Q4 2025, and $38.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 4.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.94 Bn |
| Mar 31, 2026 | 37.01 Bn |
| Dec 31, 2025 | 37.56 Bn |
| Sep 30, 2025 | 38.17 Bn |
| Jun 30, 2025 | 38.44 Bn |
| Mar 31, 2025 | 39.99 Bn |
| Dec 31, 2024 | 43.13 Bn |
| Sep 30, 2024 | 45.04 Bn |
| Jun 30, 2024 | 46.34 Bn |
| Mar 31, 2024 | 47.51 Bn |
| Dec 31, 2023 | 48.21 Bn |
| Sep 30, 2023 | 48.72 Bn |
| Jun 30, 2023 | 48.99 Bn |
| Mar 31, 2023 | 49.66 Bn |
| Dec 31, 2022 | 49.34 Bn |
| Sep 30, 2022 | 49.89 Bn |
| Jun 30, 2022 | 52.30 Bn |
| Mar 31, 2022 | 54.15 Bn |
| Dec 31, 2021 | 55.46 Bn |
| Sep 30, 2021 | 57.03 Bn |